2,3-dimethylmaleic anhydride and Neoplasm Metastasis
2,3-dimethylmaleic anhydride has been researched along with Neoplasm Metastasis in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, J; Liang, X; Shen, Q; Sun, L; Yang, J; Zhang, J; Zuo, T | 1 |
Ding, Y; Han, X; Miao, QR; Nie, G; Taleb, M; Wang, B; Yang, N; Zhang, Y; Zhao, X; Zhao, Y | 1 |
Other Studies
2 other study(ies) available for 2,3-dimethylmaleic anhydride and Neoplasm Metastasis
Article | Year |
---|---|
Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Indazoles; Maleic Anhydrides; Mice; Nanoparticles; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Polyethyleneimine; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Xenograft Model Antitumor Assays | 2019 |
Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
Topics: Animals; Cell Line, Tumor; Cell Movement; Drug Carriers; Drug Liberation; Epithelial-Mesenchymal Transition; Female; Human Umbilical Vein Endothelial Cells; Humans; Maleic Anhydrides; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Polyethyleneimine; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; RNA, Small Interfering; Tumor Microenvironment | 2018 |